It's been a couple of months since our last podcast, but we're back with a fresh episode of U2FP's CureCast. In our latest interview, Kate and Matthew talk with Dr. David Darrow, the Minneapolis neurosurgeon who is the Lead Investigator in the ESTAND trial ...

Last week we kicked off our Fuel the Journey campaign - an effort to strategically leverage our education, advocacy, and research initiatives as well as keep pace with the great legislative progress our Cure Advocacy Network (CAN) activists are making in Pennsylvania, Ohio, and Wisconsin. Today we wanted to share with you a brief video that one of our monthly donors - Elizabeth Dierdorf - sent us about why she gives monthly to U2FP ...

As Kate Willette wrote in her must-read book, Don’t Call It A Miracle, the medical breakthroughs that reduced the impact of the AIDS epidemic were brought about not by a brilliant scientist, or a rich investor, or an innovative biotech company. Rather, HIV/AIDS became treatable primarily because the brilliant scientists, rich investors, and innovative biotech companies were helped to succeed through the persistent advocacy of the affected ‘patient group’ ....

We’re always talking about the need for collaboration here at U2FP. Indeed, it’s how we approach our work everyday. We constantly ask ourselves: who can we add to help enhance this difficult SCI conversation? How can we connect this young, creative advocate with the right scientists for her documentary? How can we arrange for this device entrepreneur to meet the smart post-doc we know who might speed his prototype out of beta testing? How do we articulate the frustrations of this journey while still remaining hopeful? What are the best practices for separating out the real science from the hype - and how can we help others in the SCI Community do the same?